Search | TVST | ARVO Journals

Showing 1 – 20 of 30

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Light and transmission electron microscopy findings following selective microsecond retinal pigment epithelium photodisruption in rabbits

Christian Burri; André Schulz; Simon Salzmann; Beat Haenni; Nahoko Shintani; Boris Povazay; Chantal Dysli; Martin Sebastian Zinkernagel; Boris Victor Stanzel

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):795.

ARVO Annual Meeting Abstract June 2024

Comparable efficacy with aflibercept 8 mg at extended dosing intervals beyond q16 versus 2 mg q8 in Asian patients with nAMD in PULSAR through Week 96

Xiaodong Sun; Shih-Jen Chen; xin Zhang; Andrea Schulze; Tobias Machewitz; Min Zhao; Sergio Leal

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):220.

ARVO Annual Meeting Abstract June 2024

Aflibercept 8 mg monotherapy shows maintained efficacy over 96 weeks, with the ability to extend dosing intervals beyond every 16 weeks, in patients with PCV in the PULSAR Phase 3 trial

Rufino Silva; Tien Y Wong; Gemmy Cheung; Jeffrey S Heier; Won Ki Lee; Tomohiro Iida; xin Zhang; Tobias Machewitz; Andrea Schulze; Sergio Leal

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):219.

ARVO Annual Meeting Abstract June 2024

Pooled safety analysis of the CANDELA, PHOTON, and PULSAR trials up to 96 weeks demonstrates comparable safety profiles with aflibercept 8 mg and 2 mg

Andreas Stahl; Eric Schneider; Ursula Maria Schmidt-Ott; Claudia Tueckmantel; Andrea Schulze; Alyson J Berliner; Karen W Chu; Robert Vitti; Kimberly Reed; xin Zhang; Peter Morgan-Warren; Rohini Rao; Sergio Leal

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):217.

ARVO Annual Meeting Abstract June 2023

Tolerability and safety of intravitreal aflibercept 8 mg in the Phase 3 PULSAR trial of patients with neovascular age-related macular degeneration

Jean-Francois Korobelnik; Ursula Maria Schmidt-Ott; Andrea Schulze; Xin Zhang; Sergio Leal

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):278.

ARVO Annual Meeting Abstract June 2023

Intravitreal aflibercept 8 mg in patients with polypoidal choroidal vasculopathy (PCV): A Phase 3 PULSAR trial subgroup analysis

Tien Y Wong; Jeffrey S Heier; Xin Zhang; Tobias Machewitz; Andrea Schulze; Sergio Leal

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2240.

Review September 2022

Vitreous Substitutes as Drug Release Systems

PDF

André Schulz; Peter Szurman
TAGS: drug release, vitreous substitute, vitreous body, polymers
Trans. Vis. Sci. Tech.. 2022; 11(9):14. https://doi.org/10.1167/tvst.11.9.14

ARVO Annual Meeting Abstract June 2022

Large-Area RPE Removal by Microsecond Laser followed by hiPS-RPE transplantation

Boris V. Stanzel; Christian Burri; Sami Al-Nawaiseh; Philip Wakili; Sylvia Jane Gasparini; Gerardo Farese; Christina Kroetz; Boris Greber; Christoph Meier; Martin Frenz; Peter Szurman; André Schulz; Marius Ader

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1858.

ARVO Annual Meeting Abstract June 2022

Real-Time Optical Coherence Tomography Controlled Microsecond Laser Retinal Microsurgery: First In-vivo Results

Christian Burri; Sami Al-Nawaiseh; André Schulz; Philip Wakili; Gerardo Farese; Peter Szurman; Simon Salzmann; Ralf Brinkmann; Boris Povazay; Christoph Meier; Martin Frenz; Boris V. Stanzel

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3796 – F0217.

ARVO Annual Meeting Abstract June 2022

Short-term follow up after Large-Area RPE Removal by Microsecond Laser followed by hiPS-RPE suspension transplantation in rabbits

Sami Al-Nawaiseh; Christian Burri; André Schulz; Philip Wakili; Gerardo Farese; Christina Kroetz; Simon Salzmann; Brinkmann Ralf; Sylvia Jane Gasparini; Boris Povazay; Martin Frenz; Peter Szurman; Marius Ader; Boris V. Stanzel

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4509 – F0296.

Special Issue November 2021

Selective Large-Area Retinal Pigment Epithelial Removal by Microsecond Laser in Preparation for Cell Therapy

PDF

Christian Burri; Sami Al-Nawaiseh; Philip Wakili; Simon Salzmann; Christina Krötz; Boris Považay; Christoph Meier; Martin Frenz; Peter Szurman; André Schulz; Boris Stanzel
TAGS: cell therapy, lasers, pigment, epithelium, retinal pigment cell, laser therapy, intraoperative care
Trans. Vis. Sci. Tech.. 2021; 10(10):17. https://doi.org/10.1167/tvst.10.10.17

Includes: Multimedia, Supplemental Content

ARVO Annual Meeting Abstract June 2021

The Role of Extended Phenotyping and Functional Testing in Variant Interpretation of a Complex Patient with Overlapping Traits

Zhuo Shao; Ikuo Masuho; Anupreet Tumber; Jason Maynes; Erika Tavares; Stacy Hewson; Andreas Schulze; Peter Kannu; Kirill A Martemyanov; Ajoy Vincent

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1562.

ARVO Annual Meeting Abstract June 2021

Five-Year cumulative Incidence and Progression of Myopic Maculopathy in the German population – results from the Gutenberg Health Study

Susanne Hopf; Franziska Heidt; Christina A. Korb; Andreas Schulz; Thomas Münzel; Philipp S. Wild; Manfred E. Beutel; Irene Schmidtmann; Karl J. Lackner; Norbert Pfeiffer; Alexander K Schuster

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2882.

Articles December 2020

Alginate- and Hyaluronic Acid–Based Hydrogels as Vitreous Substitutes: An In Vitro Evaluation

PDF

André Schulz; Annekatrin Rickmann; Silke Wahl; Anja Germann; Boris Viktor Stanzel; Kai Januschowski; Peter Szurman

Trans. Vis. Sci. Tech.. 2020; 9(13):34. https://doi.org/10.1167/tvst.9.13.34

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Prevalence of hypertensive retinopathy and its risk for mortality – results from the Gutenberg Health Study

Alexander Karl-Georg Schuster; Stella Hoh; Karl Neubert; Ahmad Haj Ibrahim; Stefan Nickels; Christina A. Korb; Andreas Schulz; Thomas Muenzel; Matthias Michal; Irene Schmidtmann; Karl Lackner; Philipp Wild; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1308.

Retina November 2019

Low Birth Weight Is Linked to Age-Related Macular Degeneration: Results From the Population-Based Gutenberg Health Study (GHS)

PDF

Achim Fieß; Hisham Elbaz; Christina A. Korb; Stefan Nickels; Andreas Schulz; Thomas Münzel; Philipp S. Wild; Manfred E. Beutel; Irene Schmidtmann; Karl J. Lackner; Tunde Peto; Norbert Pfeiffer; Alexander K. Schuster
TAGS: birth weight, low birth weight infant, age-related macular degeneration, prevalence, health
Invest. Ophthalmol. Vis. Sci.. 2019; 60(14):4943-4950. https://doi.org/10.1167/iovs.19-27964

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Is the Schirmer test associated with local and systemic medication? Results of the German population-based Gutenberg Health Study (GHS)

Ulrike Hampel; Alexander Schuster; Stefan Nickels; Andreas Schulz; Karl J. Lackner; Thomas Münzel; Philipp S. Wild; Manfred Beutel; Irene Schmidtmann; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6766.

ARVO Annual Meeting Abstract July 2019

Vision-related Quality of Life when considering both eyes: Results from the German population-based Gutenberg Health Study (GHS)

Stefan Nickels; Alexander Karl-Georg Schuster; Heike Elflein; Christian Wolfram; Andreas Schulz; Thomas Münzel; Manfred Beutel; Irene Schmidtmann; Robert Patrick Finger; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1762.

ARVO Annual Meeting Abstract July 2019

Prevalence of pathologies of the vitreo-macular interface – results from the Gutenberg Health Study

Alexander Karl-Georg Schuster; Anne K Kluck; Christina A Korb; Bernhard Stoffelns; Stefan Nickels; Andreas Schulz; Thomas Münzel; Philipp S. Wild; Manfred Beutel; Irene Schmidtmann; Karl J Lackner; Tunde Peto; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3954.

Articles June 2019

Age-Related Loss of Human Vitreal Viscoelasticity

PDF

André Schulz; Silke Wahl; Annekatrin Rickmann; Jannine Ludwig; Boris V. Stanzel; Hagen von Briesen; Peter Szurman
TAGS: viscoelasticity, vitreous body
Trans. Vis. Sci. Tech.. 2019; 8(3):56. https://doi.org/10.1167/tvst.8.3.56

Includes: Supplemental Content

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Light and transmission electron microscopy findings following selective microsecond retinal pigment epithelium photodisruption in rabbits

Comparable efficacy with aflibercept 8 mg at extended dosing intervals beyond q16 versus 2 mg q8 in Asian patients with nAMD in PULSAR through Week 96

Aflibercept 8 mg monotherapy shows maintained efficacy over 96 weeks, with the ability to extend dosing intervals beyond every 16 weeks, in patients with PCV in the PULSAR Phase 3 trial

Pooled safety analysis of the CANDELA, PHOTON, and PULSAR trials up to 96 weeks demonstrates comparable safety profiles with aflibercept 8 mg and 2 mg

Tolerability and safety of intravitreal aflibercept 8 mg in the Phase 3 PULSAR trial of patients with neovascular age-related macular degeneration

Intravitreal aflibercept 8 mg in patients with polypoidal choroidal vasculopathy (PCV): A Phase 3 PULSAR trial subgroup analysis

Vitreous Substitutes as Drug Release Systems

Large-Area RPE Removal by Microsecond Laser followed by hiPS-RPE transplantation

Real-Time Optical Coherence Tomography Controlled Microsecond Laser Retinal Microsurgery: First In-vivo Results

Short-term follow up after Large-Area RPE Removal by Microsecond Laser followed by hiPS-RPE suspension transplantation in rabbits

Selective Large-Area Retinal Pigment Epithelial Removal by Microsecond Laser in Preparation for Cell Therapy

The Role of Extended Phenotyping and Functional Testing in Variant Interpretation of a Complex Patient with Overlapping Traits

Five-Year cumulative Incidence and Progression of Myopic Maculopathy in the German population – results from the Gutenberg Health Study

Alginate- and Hyaluronic Acid–Based Hydrogels as Vitreous Substitutes: An In Vitro Evaluation

Prevalence of hypertensive retinopathy and its risk for mortality – results from the Gutenberg Health Study

Low Birth Weight Is Linked to Age-Related Macular Degeneration: Results From the Population-Based Gutenberg Health Study (GHS)

Is the Schirmer test associated with local and systemic medication? Results of the German population-based Gutenberg Health Study (GHS)

Vision-related Quality of Life when considering both eyes: Results from the German population-based Gutenberg Health Study (GHS)

Prevalence of pathologies of the vitreo-macular interface – results from the Gutenberg Health Study

Age-Related Loss of Human Vitreal Viscoelasticity

To View More...

You must be signed into an individual account to use this feature.